On the other hand, variances in ADAM23 methylation profiles among BC patients with different routes of cancer cell dissemination suggest that ADAM23 plays a role in hematogenous spread, which involves the migration of cancer cells through the bloodstream. Here, ADAM23 is linked to cancer.